Enhancing Skin Cancer Early Detection and Treatment in Primary Care
NCT ID: NCT05675709
Last Updated: 2025-12-08
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
54 participants
INTERVENTIONAL
2023-04-25
2024-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Computer-Based Continuing Education for Doctors in Examination and Counseling of Patients on Skin Cancer or Weight Control
NCT00295906
Melanoma Risk Assessment & Tailored Intervention
NCT01356771
Educational Program in Skin Self-Examination To Detect Melanoma in Healthy Participants
NCT00416988
Teaching Skin Self -Examination to Melanoma Patients and Their Skin Check Partners
NCT02854657
War on Melanomaâ„¢ Public Health & Education Campaign
NCT04611568
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
I. Evaluate whether a multi-component education strategy improves the ability of PCPs to identify and triage skin cancer.
OUTLINE:
Participants are assigned to 1 of 2 groups.
PCP participants complete group training. All training participants will also be offered series of short booster teaching points delivered virtually. Participants who complete the training also take part in pre-post knowledge assessments. PCP participants may also participate in a qualitative interview.
PCPs at the two clinics who do not receive the group training will serve as study comparators.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
SCREENING
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Comparison group
PCPs at the two clinics who do not receive the group training will serve as study comparators.
No interventions assigned to this group
Other, Pragmatic
PCP participants complete group training. All training participants will also be offered series of short booster teaching points delivered virtually. Participants who complete the training also take part in pre-post knowledge assessments. PCP participants may also participate in a qualitative interview.
Training and Education
Undergo group trainings
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Training and Education
Undergo group trainings
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Clinicians at the two clinics who do not receive the intervention will serve as study comparators
* These individuals are all aged 18 years or older
* All practice members speak English
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Oregon Health and Science University
OTHER
National Cancer Institute (NCI)
NIH
OHSU Knight Cancer Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Susan A. Flocke, Ph.D.
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Susan A Flocke, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
OHSU Knight Cancer Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
OHSU Knight Cancer Institute
Portland, Oregon, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI-2022-09484
Identifier Type: REGISTRY
Identifier Source: secondary_id
STUDY00024809
Identifier Type: OTHER
Identifier Source: secondary_id
STUDY00024809
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.